AoU Research Priorities Use Cases
Does exposure to endocrine disrupting compounds (EDCs) influence the effectiveness of treatments for hormonal cancers?
EDCs are widespread in consumer products, air, and drinking water. Cancer treatments (such as tamoxifen and aromatase inhibitors for breast cancers) depend on altering the body's hormone levels. All of Us could evaluate whether EDCs interfere with cancer treatments. This study would involve assessing EDC exposure in patients during treatment and evaluating hormonal outcomes and disease progression outcomes.
Voting
2
votes
Ideate